Although S100A8, S100A9, and Aβ’s natural depot, HSA, serve as possible triggering factors and therapeutic targets in AD, their interplay with respect to Aβ binding/fibrillation remains unclear. The gene discussed is ALB; the disease is Alzheimer disease.